 Expanded clinical evaluation lovastatin EXCEL study results III Efficacy lipoproteins implications patients moderate hypercholesterolemia multicenter double-blind EXCEL Expanded Clinical Evaluation Lovastatin efficacy lovastatin plasma lipids lipoproteins participants moderate primary hypercholesterolemia Patients weeks treatment diet placebo diet lovastatin mg day mg day dosages lovastatin substantial dose-dependent reductions low-density-lipoprotein LDL -cholesterol levels mg/day mg/day magnitude effect lipoprotein percentage patients National Cholesterol Education Program NCEP goals absence coronary artery disease CAD CAD risk factors LDL-cholesterol goal mmol/L mg/dL patients placebo group mg/day mg/day lovastatin CAD CAD risk factors LDL-cholesterol goal mmol/L mg/dL placebo patients mg/day mg/day lovastatin Lovastatin high-density-lipoprotein cholesterol triglycerides dose-dependent manner adjunct prudent diet lovastatin favorable changes entire lipoprotein profile effective agent patients primary hypercholesterolemia